Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2664 of 3330
Next
>>
>
66576 to 66600 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
HCC1428	HR+	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	7444.069	0.8328	0.6471	0.9426
HCC1428	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	7444.069	0.8267	0.6343	0.9426
HCC1428	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	7444.069	0.6801	0.3287	0.9426
HCC1428	HR+	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7444.069	0.6834	0.3355	0.9426
HCC1428	HR+	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7444.069	0.6598	0.2867	0.9426
HCC1428	HR+	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7444.069	0.6280	0.2210	0.9426
HCC1428	HR+	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7444.069	0.4492	-0.1444	0.9426
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.000427	uM	7447.068	0.8390	0.7901	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.00213	uM	7447.068	0.7720	0.6984	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.0107	uM	7447.068	0.6340	0.4999	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.0533	uM	7447.068	0.5914	0.4355	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.267	uM	7447.068	0.5852	0.4258	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	1.33	uM	7447.068	0.5622	0.3903	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	6.67	uM	7447.068	0.5401	0.3554	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	33.3	uM	7447.068	0.5046	0.2985	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	167	uM	7447.068	0.5600	0.3867	1.5836
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.000427	uM	7824.068	0.9002	0.8699	1.5619
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.00213	uM	7824.068	0.7836	0.7109	1.5619
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.0107	uM	7824.068	0.6793	0.5614	1.5619
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.0533	uM	7824.068	0.6435	0.5082	1.5619
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	0.267	uM	7824.068	0.6645	0.5395	1.5619
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	1.33	uM	7824.068	0.6349	0.4953	1.5619
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	6.67	uM	7824.068	0.7008	0.5928	1.5619
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	33.3	uM	7824.068	0.6208	0.4740	1.5619
HCC1569	HER2amp	Basal A	Sirolimus	MTOR	MTOR	167	uM	7824.068	0.4475	0.1952	1.5619

|<
<<
Previous
Page 2664 of 3330
Next
>>
>
66576 to 66600 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)